Should We Adapt Existing Quality Systems for Use in Low- and Middle-Income Countries?
J Oncol Pract
.
2015 Sep;11(5):370-1.
doi: 10.1200/JOP.2015.006577.
Author
David J Kerr
1
Affiliation
1
John Radcliffe Infirmary, University of Oxford, Oxford, United Kingdom David.kerr@ndcls.ox.ac.uk.
PMID:
26384015
DOI:
10.1200/JOP.2015.006577
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antineoplastic Agents / therapeutic use*
Humans
Medical Oncology / standards*
Oncology Nursing / standards*
Substances
Antineoplastic Agents
Grants and funding
Medical Research Council/United Kingdom